Attached files

file filename
10-Q - QUARTERLY REPORT 12-31-2009 - OMNI BIO PHARMACEUTICAL, INC.omnibio10q123109_2310.htm
EX-10.2 - EXHIBIT 10.2 - OMNI BIO PHARMACEUTICAL, INC.omnibio10q123109x102_2310.htm
EX-31.2 - EXHIBIT 31.2 - OMNI BIO PHARMACEUTICAL, INC.omnibio10q123109x312_2310.htm
EX-10.3 - EXHIBIT 10.3 - OMNI BIO PHARMACEUTICAL, INC.omnibio10q123109x103_2310.htm
EX-31.1 - EXHIBIT 31.1 - OMNI BIO PHARMACEUTICAL, INC.omnibio10q123109x311_2310.htm
EX-32.1 - EXHIBIT 32.1 - OMNI BIO PHARMACEUTICAL, INC.omnibio10q123109x321_2310.htm
 
Exhibit 32.2


CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of Omni Bio Pharmaceutical, Inc. (the “Company”) on Form 10-Q for the quarter ended December 31, 2009 (the “Report”), I, Robert C. Ogden, Chief Financial Officer of the Company, hereby certify that, to the best of my knowledge:

(1)             The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
 
(2)             The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the period covered by this report.


Date:  February 4, 2010
/s/ Robert C. Ogden
 
Robert C. Ogden
 
Chief Financial Officer